Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Griffioen

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|July 1, 1991
Role of protein kinase C and cyclic adenosine monophosphate in the regulation of tissue-type plasminogen activator, plasminogen activator inhibitor-1, and platelet-derived growth factor mRNA levels in human endothelial cells. Possible involvement of proto-oncogenes c-jun and c-fosT Kooistra, P J Bosma, K Toet, et al.
Cancer Medicine|July 30, 2021
The bigger picture of shared decision making: A service design perspective using the care path of locally advanced pancreatic cancer as a caseIngeborg P M Griffioen, Judith A C Rietjens, Marijke Melles, et al.
Leukemia|August 24, 2011
Human allo-reactive CD4+ T cells as strong mediators of anti-tumor immunity in NOD/scid mice engrafted with human acute lymphoblastic leukemiaS Stevanović, M Griffioen, B A Nijmeijer, et al.
Laboratory Animals|October 1, 1992
Subcutaneous administration of HMG-CoA reductase inhibitors in hyperlipidaemic and normal ratsJ Joles, N Willekes-Koolschijn, H Koomans, et al.
BMJ Open|November 27, 2025
Use of physioLogy to evaluaTe procedural Result After percutaneous coronary intervention of Chronic Total Occlusion (ULTRA-CTO): protocol for a prospective, single-arm, multicentre, exploratory studyAlexander M Griffioen, Thomas A Meijers, Vincent Roolvink, et al.
Leukemia|April 18, 2008
HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemiaC E Rutten, S A P van Luxemburg-Heijs, M Griffioen, et al.
Journal of Interventional Cardiology|October 3, 2022
Short-Term Outcomes of Elective High-Risk PCI with Extracorporeal Membrane Oxygenation Support: A Single-Centre RegistryAlexander M Griffioen, Stijn C H Van Den Oord, Marleen H Van Wely, et al.
Leukemia|October 20, 2012
Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1R Oostvogels, M C Minnema, M van Elk, et al.
European Heart Journal. Digital Health|March 23, 2026
A machine learning model to detect falls mimicking cardiac arrest-related collapse based on wrist-derived accelerometry: the DETECT-2 studyRoos Edgar, Kambiz Ebrahimkheil, Danny Meeuwsen, et al.
Open Heart|February 17, 2025
Clinical use and impact of mechanical circulatory support for myocardial infarction-related cardiogenic shock in the Netherlands: a registry-based propensity-matched analysisMargriet Bogerd, Alexander M Griffioen, Jeroen J H Bunge, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|July 1, 1991
Role of protein kinase C and cyclic adenosine monophosphate in the regulation of tissue-type plasminogen activator, plasminogen activator inhibitor-1, and platelet-derived growth factor mRNA levels in human endothelial cells. Possible involvement of proto-oncogenes c-jun and c-fosT Kooistra, P J Bosma, K Toet, et al.
Cancer Medicine|July 30, 2021
The bigger picture of shared decision making: A service design perspective using the care path of locally advanced pancreatic cancer as a caseIngeborg P M Griffioen, Judith A C Rietjens, Marijke Melles, et al.
Leukemia|August 24, 2011
Human allo-reactive CD4+ T cells as strong mediators of anti-tumor immunity in NOD/scid mice engrafted with human acute lymphoblastic leukemiaS Stevanović, M Griffioen, B A Nijmeijer, et al.
Laboratory Animals|October 1, 1992
Subcutaneous administration of HMG-CoA reductase inhibitors in hyperlipidaemic and normal ratsJ Joles, N Willekes-Koolschijn, H Koomans, et al.
BMJ Open|November 27, 2025
Use of physioLogy to evaluaTe procedural Result After percutaneous coronary intervention of Chronic Total Occlusion (ULTRA-CTO): protocol for a prospective, single-arm, multicentre, exploratory studyAlexander M Griffioen, Thomas A Meijers, Vincent Roolvink, et al.
Leukemia|April 18, 2008
HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemiaC E Rutten, S A P van Luxemburg-Heijs, M Griffioen, et al.
Journal of Interventional Cardiology|October 3, 2022
Short-Term Outcomes of Elective High-Risk PCI with Extracorporeal Membrane Oxygenation Support: A Single-Centre RegistryAlexander M Griffioen, Stijn C H Van Den Oord, Marleen H Van Wely, et al.
Leukemia|October 20, 2012
Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1R Oostvogels, M C Minnema, M van Elk, et al.
European Heart Journal. Digital Health|March 23, 2026
A machine learning model to detect falls mimicking cardiac arrest-related collapse based on wrist-derived accelerometry: the DETECT-2 studyRoos Edgar, Kambiz Ebrahimkheil, Danny Meeuwsen, et al.
Open Heart|February 17, 2025
Clinical use and impact of mechanical circulatory support for myocardial infarction-related cardiogenic shock in the Netherlands: a registry-based propensity-matched analysisMargriet Bogerd, Alexander M Griffioen, Jeroen J H Bunge, et al.
Pageof 6